GBT

Global Blood Therapeutics, Inc.
GBT

Overview Fund Activity
Delisted

GBT was delisted on the 4th of October, 2022.

Back to rankings

203 hedge funds and large institutions have $2.4B invested in Global Blood Therapeutics, Inc. in 2022 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 78 increasing their positions, 62 reducing their positions, and 30 closing their positions.

Holders
203
Holders Change
-2
Holders Change %
-0.98%
% of All Funds
3.21%
Holding in Top 10
10
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+42.86%
% of All Funds
0.16%
New
31
Increased
78
Reduced
62
Closed
30
Calls
$13.9M
Puts
$14M
Net Calls
-$21K
Net Calls Change
-$4.27M

Top Buyers

1
O
1
OrbiMed
New York
$54.6M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$31.9M
3
Goldman Sachs
3
Goldman Sachs
New York
$63.5M
4
LGM
4
Logos Global Management
California
$43.3M
5
PA
5
Perceptive Advisors
New York
$135M

Top Sellers

1
Capital World Investors
1
Capital World Investors
California
$0
2
APM
2
Avidity Partners Management
Texas
$0
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$0
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$142M
5
Voloridge Investment Management
5
Voloridge Investment Management
Florida
$2.05M
Name Market Value Shares Shares
Change 		Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$209M 6,024,262 +31,120 +0.5%
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$194M 5,603,255 +120,091 +2%
BlackRock
3
BlackRock
New York
$183M 5,284,511 -68,545 -1%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$142M 4,091,699 -190,702 -4%
PA
5
Perceptive Advisors
New York
$135M 3,892,493 +442,578 +13%
State Street
6
State Street
Massachusetts
$120M 3,456,012 +284,877 +9%
BBA
7
Baker Bros. Advisors
New York
$115M 3,314,765 – –
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$110M 3,181,299 -79,386 -2%
DTC
9
Deep Track Capital
Connecticut
$79.8M 2,304,683 +304,683 +15%
Citadel Advisors
10
Citadel Advisors
Florida
$68.1M 1,965,932 +280,076 +17%
Goldman Sachs
11
Goldman Sachs
New York
$63.5M 1,833,720 +595,983 +48%
Bank of America
12
Bank of America
North Carolina
$62.9M 1,817,187 +260,871 +17%
O
13
OrbiMed
New York
$54.6M 1,576,600 +1,576,600 New
YCM
14
Yiheng Capital Management
California
$52M 1,501,382 +225,582 +18%
KCM
15
Kynam Capital Management
New Jersey
$46.4M 1,339,322 +346,373 +35%
CC
16
Casdin Capital
New York
$45.9M 1,325,000 – –
LGM
17
Logos Global Management
California
$43.3M 1,250,000 +500,000 +67%
FFM
18
Fairmount Funds Management
Pennsylvania
$41M 1,182,307 +439,307 +59%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$37.6M 1,086,624 +12,589 +1%
PBA
20
Paradigm Biocapital Advisors
New York
$33.5M 966,827 +186,347 +24%
Point72 Asset Management
21
Point72 Asset Management
Connecticut
$31.9M 920,200 +736,729 +402%
CS
22
Candriam SCA
Luxembourg
$26.2M 756,708 +108,369 +17%
BNP Paribas Asset Management
23
BNP Paribas Asset Management
France
$22.3M 642,904 +242,117 +60%
Franklin Resources
24
Franklin Resources
California
$21M 607,326 -3,584 -0.6%
N
25
Natixis
France
$20.9M 604,200 +162,620 +37%
1
2 3 4 5